Cargando…
P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW.
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431145/ http://dx.doi.org/10.1097/01.HS9.0000970580.01478.5b |
| _version_ | 1785091131577466880 |
|---|---|
| author | Gundesen, Michael Schjesvold, Fredrik Vangsted, Annette Helleberg, Carsten Haukås, Einar Silkjær, Trine Todorescu, Elena Amdi Jensen, Bo Slørdahl, Tobias S. Thor Asmussen, Jon Nahi, Hareth Waage, Anders Abildgaard, Niels Lund, Thomas |
| author_facet | Gundesen, Michael Schjesvold, Fredrik Vangsted, Annette Helleberg, Carsten Haukås, Einar Silkjær, Trine Todorescu, Elena Amdi Jensen, Bo Slørdahl, Tobias S. Thor Asmussen, Jon Nahi, Hareth Waage, Anders Abildgaard, Niels Lund, Thomas |
| author_sort | Gundesen, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431145 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311452023-08-17 P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW. Gundesen, Michael Schjesvold, Fredrik Vangsted, Annette Helleberg, Carsten Haukås, Einar Silkjær, Trine Todorescu, Elena Amdi Jensen, Bo Slørdahl, Tobias S. Thor Asmussen, Jon Nahi, Hareth Waage, Anders Abildgaard, Niels Lund, Thomas Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431145/ http://dx.doi.org/10.1097/01.HS9.0000970580.01478.5b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Gundesen, Michael Schjesvold, Fredrik Vangsted, Annette Helleberg, Carsten Haukås, Einar Silkjær, Trine Todorescu, Elena Amdi Jensen, Bo Slørdahl, Tobias S. Thor Asmussen, Jon Nahi, Hareth Waage, Anders Abildgaard, Niels Lund, Thomas P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW. |
| title | P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW. |
| title_full | P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW. |
| title_fullStr | P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW. |
| title_full_unstemmed | P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW. |
| title_short | P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW. |
| title_sort | p919: treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431145/ http://dx.doi.org/10.1097/01.HS9.0000970580.01478.5b |
| work_keys_str_mv | AT gundesenmichael p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT schjesvoldfredrik p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT vangstedannette p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT hellebergcarsten p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT haukaseinar p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT silkjærtrine p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT todorescuelena p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT amdijensenbo p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT slørdahltobiass p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT thorasmussenjon p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT nahihareth p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT waageanders p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT abildgaardniels p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw AT lundthomas p919treatmentofpatientswithmultiplemyelomawithzoledronicacidforfouryearsinsteadoftwoyearsdecreasesriskofprogressivebonediseasewithoutincreasingriskofosteonecrosisofthejaw |